| Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder H Miyamoto, JL Yao, A Chaux, Y Zheng, I Hsu, K Izumi, C Chang, ... BJU international 109 (11), 1716-1726, 2012 | 226 | 2012 |
| Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor JW Hsu, I Hsu, D Xu, H Miyamoto, L Liang, XR Wu, CR Shyr, C Chang The American journal of pathology 182 (5), 1811-1820, 2013 | 119 | 2013 |
| Defects of prostate development and reproductive system in the estrogen receptor-α null male mice M Chen, I Hsu, A Wolfe, S Radovick, KH Huang, S Yu, C Chang, ... Endocrinology 150 (1), 251-259, 2009 | 89 | 2009 |
| Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development I Hsu, KL Chuang, S Slavin, J Da, WX Lim, ST Pang, JH O’Brien, S Yeh Carcinogenesis 35 (3), 651-661, 2014 | 80 | 2014 |
| Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo I Hsu, CR Yeh, S Slavin, H Miyamoto, GJ Netto, M Muyan, XR Wu, ... Oncotarget 5 (17), 7917, 2014 | 74 | 2014 |
| TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation KM Lee, IW Hsu, WY Tarn Nucleic acids research 38 (10), 3340-3350, 2010 | 70 | 2010 |
| Role of oestrogen receptors in bladder cancer development I Hsu, S Vitkus, J Da, S Yeh Nature Reviews Urology 10 (6), 317-326, 2013 | 69 | 2013 |
| Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor … CR Yeh, S Slavin, J Da, I Hsu, J Luo, GQ Xiao, J Ding, FJ Chou, S Yeh Molecular cancer 15, 1-14, 2016 | 65 | 2016 |
| Phosphorylation of Y14 modulates its interaction with proteins involved in mRNA metabolism and influences its methylation IW Hsu, M Hsu, C Li, TW Chuang, RI Lin, WY Tarn Journal of Biological Chemistry 280 (41), 34507-34512, 2005 | 53 | 2005 |
| Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts RJ Hung, IWJ Hsu, JL Dreiling, MJ Lee, CA Williams, MD Oberst, ... American Journal of Physiology-Cell Physiology 286 (5), C1159-C1169, 2004 | 47 | 2004 |
| Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M QQ Li, I Hsu, T Sanford, R Railkar, N Balaji, C Sourbier, C Vocke, ... Cellular and molecular life sciences 75, 939-963, 2018 | 38 | 2018 |
| Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment CR Yeh, I Hsu, W Song, H Chang, H Miyamoto, GQ Xiao, L Li, S Yeh American journal of cancer research 5 (3), 1146, 2015 | 38 | 2015 |
| Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach QQ Li, JJ Hao, Z Zhang, I Hsu, YI Liu, Z Tao, K Lewi, AR Metwalli, ... International Journal of Oncology 48 (6), 2591-2607, 2016 | 31 | 2016 |
| Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma W Song, D He, Y Chen, CR Yeh, I Hsu, Q Huang, X Zhang, LSS Chang, ... Molecular oncology 12 (12), 2055, 2018 | 25 | 2018 |
| Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development S Vitkus, CR Yeh, HH Lin, I Hsu, J Yu, M Chen, S Yeh Molecular Endocrinology 27 (1), 38-49, 2013 | 17 | 2013 |
| Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer Z Shang, Y Li, I Hsu, M Zhang, J Tian, S Wen, R Han, EM Messing, ... Oncotarget 7 (19), 27325, 2016 | 16 | 2016 |
| TARGETING NEWLY IDENTIFIED ER beta/TGF-beta 1/SMAD3 SIGNALS WITH THE FDA-APPROVED ANTI-ESTROGEN FASLODEX OR AN ER beta SELECTIVE ANTAGONIST IN RENAL CELL CARCINOMA W Song, H Xu, KM Doersch, FJ Chou, D He, Y Chen, I Hsu, CR Yeh, ... Journal of Urology 201 (4), E206-E207, 2019 | | 2019 |
| MP16-04 TARGETING NEWLY IDENTIFIED ERβ/TGF-β1/SMAD3 SIGNALS WITH THE FDA-APPROVED ANTI-ESTROGEN FASLODEX OR AN ERβ SELECTIVE ANTAGONIST IN RENAL CELL CARCINOMA W Song, H Xu*, KM Doersch, FJ Chou, D He, Y Chen, I Hsu, CR Yeh, ... The Journal of Urology 201 (Supplement 4), e206-e207, 2019 | | 2019 |
| Mechanisms underlying the inhibitory effect of CRT0066101 on bladder cancer growth in vitro and in vivo Q Li, I Hsu, R Railkar, T Sanford, PK Agarwal Cancer Research 78 (13_Supplement), 4301-4301, 2018 | | 2018 |
| Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and in vivo through induction of cell cycle arrest at the G2-M phase. QQ Li, I Hsu, T Sanford, RS Railkar, PK Agarwal Journal of Clinical Oncology 35 (15_suppl), e16024-e16024, 2017 | | 2017 |
